Rezultati pretraživanja
  1. 3. pro 2019.

    The posters are up!. Thanks to 24th Nina Buscombe Award for the wonderful support

  2. 4. pro 2019.

    “Palliative care is not just about managing physical symptoms, a holistic approach is needed involving family, friends, neighbours and wider community services - it’s about adding life to days not just days to life” Luc Deliens (Belgium)

  3. 4. pro 2019.

    Excellent talk by Julian Grosskreutz highlighting that the motoneuronal network is more expansive than we may think, the semantics of the term network, and motor neuron susceptibility to stress, perhaps explaining their vulnerability in a wider cortical disease

  4. 6. pro 2019.

    Leaving the with new ideas, increased ambition, and renewed hope. Thank you to all who presented, hosted, and came to chat at the poster session. What a fabulous three days. And thank you to and for helping me get here!

    Prikaži ovu nit
  5. 3. pro 2019.

    Tofersen as promising therapeutic option for ALS. Results from phase 1 show treatment is safe and tolerable. Responder/non-responder analysis should be interpreted with caution. Interesting decline in neurofilament and late stage clinical trial is indicated

  6. 6. pro 2019.

    What a great end of an excellent meeting by receiving the MND Clinical Poster prize for optimizing the use of the ALSFRS-R! The time may have come to say goodbye to the total score and make better use of its domain information in clinical trials.

  7. 4. pro 2019.

    Walk to D’Feet MND in Perth

  8. 6. pro 2019.

    This year ends on a high note with very positive feedback and recognition for the work of our lab! From the PG award , the elegant presentation and the poster prize winner Nora Markus, we leave 2019 full of enthusiasm and motivation

  9. 5. pro 2019.

    Congrats to my student Laura Reale for winning the joint Biomedical Poster Prize at . Shortlisted from 500 abstracts and such a great achievement for a brilliant student at the start of her PhD. Can't wait to see what she can do with the next few years!!

  10. Watch below as our Chief Executive, , shares her thoughts on this year's International Symposium. 850+ of the best MND research minds came together. Visit 🌐 to recap on what's been discussed!

  11. 5. pro 2019.

    Lots of discussion at the evening poster session

  12. 5. pro 2019.

    Thought-provoking pilot study assessing the impact of dysphagia training plus dietary intake of extra virgin olive oil in people living with MND... Dr Vicky Flood describes maintained swallow function in those in the combined group

  13. 5. pro 2019.

    Good to see the Register featured at the this year. A really important project for Will lead us to new understandings and drive our research and services in the future. Please register if you are living with MND and haven’t already!

  14. 5. pro 2019.

    Good to see the Head Up collar, developed at SITraN on display at

  15. 4. pro 2019.

    All / research posters set up in the room... With my precise(ish) calculations, you'd walk approx. 700m through all the poster lanes!🚶‍♀️🚶‍♂️ – mjesto: Perth Convention & Exhibition Centre

  16. 5. pro 2019.

    Last session of for this year is on brain 🧠 computer 💻 interface. Really interesting and developing field. It’s been an excellent conference and I hope our delegates go home inspired by the science and connections and with urgency in their hearts 💕

  17. 5. pro 2019.

    Fantastic talk from . About 30% patients with ALS have loss of appetite which worsens as disease progresses. Early interventions to address loss of appetite could slow body weight loss and improve disease outcomes

  18. 4. pro 2019.

    From session to session! Thank you for a great meeting so far

  19. 6. pro 2019.

    All of the University of Edinburgh contingent that made it to the other side of the world. Thanks, Perth, has been great, learnt a lot, met new people and caught up with old friends

  20. 3. pro 2019.

    Many interesting talks about innovations in clinical trial design evaluating multiple treatments simultaneously, PET-based pharmacodynamic markers and promising therapeutic strategies using stem cells and antisense oligonucleotides

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.